» Articles » PMID: 32019293

Left Ventricular Response After Cardiac Resynchronization Therapy is Related to Early Left Atrial Volume Reduction

Overview
Specialty General Medicine
Date 2020 Feb 6
PMID 32019293
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: The current study aimed to elucidate a time-course change in left atrial volume after cardiac resynchronization therapy (CRT) and to verify factors associated with left atrial volume reduction (LAVR) and its prognostic implications.

Methods: The records of 97 patients were retrospectively reviewed after CRT. Echocardiographic data were analyzed at baseline before CRT, at early follow-up (FU) (≤ 1 year, median 6 months), and at late FU (median 30 months). Left ventricular volume response (LVVR) was defined as 15% reduction in left ventricular (LV) end-systolic volume (ESV). LAVR was classified into two groups by the median value at early FU: LAVR (≥ 7.5%) and no LAVR (< 7.5%).

Results: LV ESV index continuously decreased from baseline to early FU and from early FU to late FU (106.1 ± 47.4 mL/m2 vs. 87.6 ± 51.6 mL/m2 vs. 72.5 ± 57.1 mL/m2). LA volume index decreased from baseline to early FU, but there were no reductions thereafter (51.8 ± 21.9 mL/m2 vs. 45.1 ± 19.6 mL/m2 vs. 44.9 ± 23.0 mL/m2). The only echocardiographic factor associated with LAVR was change in E velocity (odds ratio [OR], 1.04; p = 0.002). Early LAVR (OR, 10.05; p = 0.002) was an independent predictor for late LVVR.

Conclusion: LAVR was related to reduction in E velocity, suggesting its relation with optimization of LV filling pressure. Early LAVR was a predictor for LVVR to CRT in long-term FU.

Citing Articles

What does left atrial structural remodeling mean in cardiac resynchronization therapy?.

Shin S Korean J Intern Med. 2020; 35(5):1070-1071.

PMID: 32921008 PMC: 7487307. DOI: 10.3904/kjim.2020.397.

References
1.
Bax J, Abraham T, Barold S, Breithardt O, Fung J, Garrigue S . Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. J Am Coll Cardiol. 2005; 46(12):2168-82. DOI: 10.1016/j.jacc.2005.09.020. View

2.
Kuperstein R, Goldenberg I, Moss A, Solomon S, Bourgoun M, Shah A . Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT trial. Circ Heart Fail. 2013; 7(1):154-60. DOI: 10.1161/CIRCHEARTFAILURE.113.000748. View

3.
Solomon S, Foster E, Bourgoun M, Shah A, Viloria E, Brown M . Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation. 2010; 122(10):985-92. DOI: 10.1161/CIRCULATIONAHA.110.955039. View

4.
Brenyo A, Link M, Barsheshet A, Moss A, Zareba W, Wang P . Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011; 58(16):1682-9. DOI: 10.1016/j.jacc.2011.07.020. View

5.
Mullens W, Kepa J, De Vusser P, Vercammen J, Rivero-Ayerza M, Wagner P . Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy. Am J Cardiol. 2011; 108(3):409-15. DOI: 10.1016/j.amjcard.2011.03.060. View